120eP Utility of metabolic biomarkers on FDG PET/CT to predict the histological grade of soft tissue sarcomas
ESMO Rare Cancers · 2026-03 · 5 · 100326
DOI: 10.1016/j.esmorc.2026.100326 ↗Kurz gefasst
Fachartikel in der Zeitschrift ESMO Rare Cancers, 2026-03. Verfasst von S. Khatri und 9 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Khatri, S., Purandare, N., Rajan, R., Shah, S., Agrawal, A., Puranik, A., Choudhury, S., Ghosh, S., Dev, I., & Venkatachalam, M. (2026). 120eP Utility of metabolic biomarkers on FDG PET/CT to predict the histological grade of soft tissue sarcomas. ESMO Rare Cancers, 5, 100326. https://doi.org/10.1016/j.esmorc.2026.100326
Vancouver
Khatri S, Purandare N, Rajan R, Shah S, Agrawal A, Puranik A, et al. 120eP Utility of metabolic biomarkers on FDG PET/CT to predict the histological grade of soft tissue sarcomas. ESMO Rare Cancers. 2026;5:100326. doi:10.1016/j.esmorc.2026.100326
BibTeX
@article{Khatri2026,
author = {Khatri, S. and Purandare, N. and Rajan, R. and Shah, S. and Agrawal, A. and Puranik, A. and Choudhury, S. and Ghosh, S. and Dev, I. and Venkatachalam, M.},
title = {120eP Utility of metabolic biomarkers on FDG PET/CT to predict the histological grade of soft tissue sarcomas},
journal = {ESMO Rare Cancers},
year = {2026},
volume = {5},
pages = {100326},
doi = {10.1016/j.esmorc.2026.100326}
}
EUVIMED